{"id":4968,"date":"2025-01-20T12:23:05","date_gmt":"2025-01-20T11:23:05","guid":{"rendered":"https:\/\/hetcongresbureau.nl\/evenement\/3d-pharmaprint-healthcare-symposium\/"},"modified":"2026-04-14T11:31:36","modified_gmt":"2026-04-14T09:31:36","slug":"3d-pharmaprint-healthcare-symposium","status":"publish","type":"tribe_events","link":"https:\/\/hetcongresbureau.nl\/en\/evenement\/3d-pharmaprint-healthcare-symposium\/","title":{"rendered":"3D PharmaPrint Healthcare Symposium"},"content":{"rendered":"

The 1st<\/sup><\/span> edition of the 3D PharmaPrint Healthcare Symposium will take place on Tuesday March 18th<\/sup><\/span> in Rotterdam, The Netherlands.<\/p>\n

The PharmaPrint Healthcare Symposium, a collaborative initiative by TNO and Erasmus Medical Center, seeks to bridge the gap between pharmaceuticals and healthcare through the lens of 3D printing. By uniting thought leaders and pioneers in the field, our objective is to shape the future of healthcare, fostering precision medicine, and pushing the boundaries of what’s achievable in the realm of healthcare. Our goal is to create a dynamic space for experts, researchers, and industry leaders to exchange insights, accelerate innovation, and pave the way for a future where personalized medicine meets cutting-edge technology.<\/p>\n

 <\/p>\n

Program<\/strong><\/h2>\n

The preliminary program is available here<\/a>. Sneak preview of the speakers and panel members can be found below.<\/p>\n


\nRegistration<\/strong><\/h2>\n

For registration click on ‘Online registration’ (right side of the page)
\nYou can register for the symposium until Monday March10th<\/sup>, 2025<\/strong>.<\/p>\n

 <\/p>\n

Venue<\/strong><\/h2>\n

\"\"<\/p>\n

Buitenplaats Rozenlust
\nParklaan 11
\n<\/span>3016 BA Rotterdam
\nWebsite Rozenlust: https:<\/a> \/\/rozenlust.nl\/ <\/span><\/p>\n

 <\/p>\n

 <\/p>\n

Poster<\/strong><\/h2>\n

If you are interested in presenting a poster, please submit an abstract (up to 200 words) to 3DPPHSymposium@erasmusmc.nl<\/a> by February10th<\/sup><\/strong><\/span>.<\/p>\n

 <\/p>\n

Accreditation<\/strong><\/h2>\n

Accreditation requested by NVZA and KNMP
\n<\/strong><\/p>\n

 <\/p>\n

Accessibility venue:<\/strong><\/h2>\n

Public Transport<\/em>
\n<\/strong>Streetcar line 7 (from Rotterdam Central Station) stops 400 meters away. Metro station Leuvehaven is a 5-minute walk. By bike, it’s about 10 minutes from Rotterdam Central Station.
\nFerry<\/em>
\nYou can also arrive by ferry. Disembark at Rotterdam Erasmus Bridge.
\nCar & parking<\/em>
\nAccessible by car via the A16 (exit 25 Rotterdam Centrum) or the A13 (exit Stadhoudersweg).
\nYou can park on our premises, but there are limited spots available. Parking at Erasmus MC is also available, this will be within a short 10 minute walk.<\/p>\n

 <\/p>\n

City, hotels & travel<\/strong><\/h2>\n

Visit this website<\/a> for more information about hotels, drinks & dining and travel in Rotterdam.<\/p>\n

Hotels nearby the venue Buitenplaats Rozenlust:<\/em>
\nDoubleTree by Hilton Rotterdam Centre – website<\/a>
\nSonder Rose – website<\/a>
\nBilderberg Parkhotel Rotterdam – website<\/a><\/p>\n

 <\/p>\n

Organization<\/strong><\/h2>\n
\"\"

Liesbeth Ruijgrok<\/p><\/div>\n

\"\"

Julian Quodbach<\/p><\/div>\n

\"\"

Jayeeta Sengupta<\/p><\/div>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

\"\"

Amanda Holst<\/p><\/div>\n

\"\"

Eveline van Kampen<\/p><\/div>\n

\"\"

Sejad Ayyoubi<\/p><\/div>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n


\nLiesbeth Ruijgrok <\/strong><\/em>is a hospital pharmacist and researcher that is highly motivated to improve the availability of suitable medicines for neglected patient groups. She has been working in Erasmus MC since 2018. She is Principal Investigator in the Research Pillar “Drug Innovation and Drug Development” of the Hospital Pharmacy. She is an enthusiastic collaborator in several scientific projects that concern in-academia development of drugs, varying from small molecules to cell therapy products (ATMP) and cancer vaccines. Since 2019 she has been working in the field of 3D-printing, in close collaboration with TNO. She sees that the 3D-printing technology can substantially enlarge personalized treatment options since it allows for flexible and tuneable drug compounding. She is affiliated to a growing Dutch and European consortium in this field and currently supervises 4 PhD students on the topic of 3D pharmaprinting. Her ultimate goal: to bring this exciting new technology as soon as possible to the benefit of patients!<\/p>\n

Julian Quodbach<\/strong><\/em> is a pharmacist by training with a PhD in pharmaceutics from Heinrich Heine University D\u00fcsseldorf in Germany. Since 2015 he is researching 3D printing as manufacturing tool for pharmaceutical products. After a postdoc at the Drug Delivery Group at Uppsala University, Sweden in 2019, Julian Quodbach returned to D\u00fcsseldorf to continue his work on 3D printing. In January 2022, Julian joined the Utrecht Institute for Pharmaceutical Sciences at Utrecht University, The Netherlands as Assistant Professor. There, he connects his academic work on 3D printing of medicines with clinical translation and application.<\/p>\n

Dr. Jayeeta Sengupta<\/strong><\/em> is a biologist specializing in drug development, nanomedicine, and bridging research with business innovation. She has held both academic and industry positions globally in different organizations. She has contributed to impactful research and authored multiple publications. Her current role is Program Manager Science & Technology, Unit High Tech Industry at TNO.<\/p>\n

Amanda Holst<\/strong> is a PhD candidate at Erasmus MC’s Hospital Pharmacy in Rotterdam, Netherlands, specializing in the 3D printing of pediatric medications. She holds a degree in biopharmaceutical sciences from Leiden University, where she combined research and business specializations during her master’s. Her research aims to harness 3D printing technology to create personalized medicines tailored to the unique needs of pediatric patients. This innovative approach allows for customization in dosage, shape, flavor, and drug combinations, improving both treatment efficacy and patient compliance. The project encompasses the development of optimal formulations, followed by clinical trials to assess the effectiveness and safety of the 3D-printed medications.<\/p>\n

Eveline van Kampen<\/strong> is a PhD candidate and research coordinator at Erasmus MC’s Hospital Pharmacy in Rotterdam, Netherlands. With a background in chemical engineering and bio-pharmaceutical sciences, she brings a unique perspective to her research. Her work focuses on innovative pharmaceutical technologies, particularly the application of 3D printing to develop age- and dose-appropriate medications for pediatric patients. Before joining Erasmus MC, she conducted research exploring hot-melt extrusion for pharmaceutical formulations. She also served as a clinical trial manager at Hematology Oncology Adult Research Netherlands in Rotterdam. Her academic journey includes a Master’s in Bio-Pharmaceutical Sciences from Leiden University and a Bachelor’s in Chemical Engineering from the University of Twente. Throughout her career, Eveline has supervised various MSc students and contributed to publications on topics such as 3D printing of medicines and vaccine delivery systems.<\/p>\n

Sejad Ayyoubi<\/strong> is pharmacist from background with several years of experience in developing personalized, 3D printed medicines. He is currently doing his PhD in the same topic at the Erasmus MC hospital pharmacy. The aim of his PhD is to translate this innovation from concept to clinical implementation. His work consists of the development, quality, costs, and clinical testing of 3D pharmaceuticals, with a focus on special drug release profiles.<\/p>\n

 <\/p>\n

Sneak preview speakers\/panel members<\/strong><\/h2>\n
\"\"

Mari\u00eblle Bouma<\/p><\/div>\n

\"\"

Alvaro Goyanes<\/p><\/div>\n

\"\"

Ricarda Leister<\/p><\/div>\n

\"\"

Ali Nasser Eddine<\/p><\/div>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

\"\"

Margot Niewenweg-Camp<\/p><\/div>\n

\"\"

Patrick van Oirschot<\/p><\/div>\n

\"\"

Mattias Paulsson<\/p><\/div>\n

\"\"

Holger Reinhoff<\/p><\/div>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

\"\"

Niklas Sandler<\/p><\/div>\n

\"\"

Kirsten Schimmel<\/p><\/div>\n

\"\"

Jesse Swen<\/p><\/div>\n

\"\"

Maxime Annereau<\/p><\/div>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

\"\"

Johan de Graaf<\/p><\/div>\n

\"\"

Nico van Meeteren<\/p><\/div>\n

\"\"

Ren\u00e9 Th\u00fcrmer<\/p><\/div>\n

\"\"

Laurens Schulpen<\/p><\/div>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

\"\"

Tilmann Spitz (GoatAM)<\/p><\/div>\n

\"\"

Niels Ouwerkerk<\/p><\/div>\n

\"\"

Robert Flint<\/p><\/div>\n

\"\"

Karel Stolper<\/p><\/div>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

Maxime Annereau (Gustave Roussy)
\n<\/strong>Maxime Annereau has been a hospital pharmacist at Gustave Roussy since 2013, specializing in pediatric oncology and hematology. A former Paris hospital resident, he holds a Master’s degree in oncology (Universit\u00e9 Paris-Saclay, 2010) and is currently pursuing a PhD (Universit\u00e9 Paris-Saclay, 2022-2025). He contributed to the creation of a translational unit dedicated to innovative drug formulations and played a key role in developing a pediatric form of temozolomide, which was launched on the European market in collaboration with a start-up. As head of Gustave Roussy’s galenic and analytical translational unit, he focuses on unmet pharmaceutical needs and innovative projects. In 2024, he co-founded Pharma 3DPI to promote 3D printing of medicines.<\/p>\n

 <\/p>\n

Mari\u00eblle Bouma (Dutch Health and Youth Care Inspectorate (IGJ))
\n<\/strong><\/em>Mari\u00eblle Bouma is a pharmacist by training from the University of Groningen and worked for over twenty years in pharmaceutical and food industry. She worked in as well quality as manufacturing roles for several companies before she started as GMP Inspector for the Dutch Health and Youth Care Inspectorate (IGJ) in 2023. Her main focus is on industrial manufacturing of medicinal products.<\/p>\n

 <\/p>\n

Robert Flint (Erasmus MC)
\n<\/strong><\/em>Robert Flint is a hospital pharmacist and clinical pharmacologist in the Erasmus MC Sophia Children’s Hospital with a focus on intensive care neonatology and obstetrics. Besides patient care, his research aims to determine optimal drug dosages for the most vulnerable premature born infants and during pregnancy. This has led to multiple descriptions of the pharmacokinetic profile of currently used drugs in (preterm) neonates, dose-finding exercises relating PK with PD, and a large ongoing randomized controlled drug trial. Furthermore, from his clinical pediatric perspective he collaborates to enable safe and acceptable drug formulations for all ages. As an editorial board member of the Dutch pediatric drug formulary, Robert has short connections to implement these findings in clinical practice.<\/p>\n

 <\/p>\n

Johan de Graaf (Dutch Pituitary Foundation)<\/em>
\n<\/strong>Johan de Graaf is well-known in the field of patient advocacy, particularly for those with hypothalamic and pituitary conditions. Diagnosed with a tumor in the hypothalamic and pituitary region in 2007, Johan’s personal experience with the condition led him to become deeply involved in patient support and advocacy.
\nHe has been the Chair of the Dutch Pituitary Foundation since 2015, where he has worked tirelessly to support patients and raise awareness about pituitary disorders. Johan also co-chairs the patient board of the European Society for Endocrinology and is involved in the European Reference Network on Rare Endocrine Conditions (Endo-ERN) as the ePAG co-chair for the Main Thematic Group on Hypothalamic and Pituitary Conditions.
\nIn addition to his advocacy work, Johan has contributed to health technology assessment (HTA) bodies on the reimbursement of new medicines and is has been a national expert for the European Medicines Agency (EMA). His efforts in patient advocacy have been recognized with his election to the EURORDIS Board of Directors in 2024. Within the context of Endo-ERN Johan performed research on the unmet medical or social needs of patients living with a rare endocrine disorder. Johan’s dedication to improving the lives of those with pituitary conditions is evident through his extensive involvement in various organizations and his continuous efforts to advance research, education, and patient support. <\/em><\/p>\n

 <\/p>\n

Alvaro Goyanes (Fabrx, USC)
\n<\/strong><\/em>Alvaro is co-founder and CEO at FABRX, the first company focused on developing 3D printing technology for fabrication of personalized medicines and medical devices. He is also Lecturer at the Faculty of Pharmacy – University of Santiago de Compostela (Spain) and Honorary Lecturer at University College London – School of Pharmacy (UK). Alvaro is one of the first researchers to evaluate the opportunities of 3D printing using new 3D printing technologies to manufacture oral dosage forms and medical devices. He has been listed among the World’s Most Highly Influential Researchers for six years from 2019 by Web of Science and he is a recognized world expert in 3D printing of medicines. He is Director and cofounder of the Pharmaceutical 3D Printing Initiative, consortium dedicated to advancing the utilization of 3D printing in the pharmaceutical field. He holds a PhD in Pharmaceutics from University of Santiago de Compostela (Spain) and he worked for 3 years as a Registered Pharmacist, thus has first-hand knowledge of the needs in terms of medicines in the community pharmacy.<\/p>\n

 <\/p>\n

Ricarda Leister (Meggle Pharma Excipients & Technology)
\n<\/strong><\/em>Ricarda is an accomplished leader with over 20 years in the pharmaceutical industry. As Head of Research & Development at MEGGLE Excipients, she leads a team driving innovation in excipients and technology, providing formulation support for pharmaceutical companies. She has worked with renowned companies like BASF, Boehringer Ingelheim, Merck, Procter & Gamble, and STADA. Ricarda holds an MBA and a degree in Pharmaceutical Engineering. Her expertise includes solid dosage forms, with a passion for advancing manufacturing science, technology, and digitalization to foster innovation and create customer value.<\/p>\n

 <\/p>\n

Ali Nasser Eddine (DiHeSys)<\/strong><\/em><\/p>\n

 <\/p>\n

Nico van Meeteren (Erasmus MC, Executive Director Top Sector Life Sciences and Health)
\n<\/strong>Van Meeteren earned his PhD as a Neuroscientist from the Rudolf Magnus Institute for Neurosciences of the Utrecht University in 1994. After 18 years of innovation and scientific validation of prevention, care and cure concepts and educational MSc models in connection with the University Medical Centre Utrecht, he became Director of Innovation “Healthy for Live” at TNO in 2008. Van Meeteren was Professor at Maastricht University and held board memberships of amongst others the National Platform Sports and Physical Activity, Body@Work, and the Center for Care Technology Research. Since 2015, he has served as the Executive Director and Secretary General of the Top Sector Life Sciences & Health (Health~Holland). Furthermore, Van Meeteren is Professor of Perioperative Health at Erasmus Medical Center. Related to these appointments he holds several governance positions within the societal theme “Health and Care” of the Dutch government’s Mission-driven Innovation Policy.<\/p>\n

 <\/p>\n

Margot Niewenweg-Camp (Dutch Health and Youth Care Inspectorate (IGJ))
\n<\/strong><\/em>Margot Nieuwenweg-Camp is a pharmacist by education, graduated from Utrecht University. Before joining the Dutch Health and Youth Care Inspectorate (IGJ) in 2020 she worked in several public pharmacies with compounding facilities in the Netherlands. At the IGJ she always worked in the field of medicinal products. The last two years as a GMP inspector with a special interest in drug manufacturing in (hospital) pharmacies including 3D printing.<\/p>\n

 <\/p>\n

Patrick van Oirschot (GPP Support)
\n<\/strong><\/em>Patrick van Oirschot is an experienced consultant in hospital pharmacy and a managing partner at GPP Support since 2013. He has a strong background in project management, strategic consulting, and new business development. Patrick has been involved in various leadership roles, from new business development for the pharma wholesaler to founding the Pharmacy Leadership Foundation. He is also the co-founder of the Asclepius Project, where he, along with pharmacists from over seven countries, is committed to raising awareness, developing, and transitioning to Closed Loop Medication Management.
\nHe holds a master’s degree in econometrics and has published several white papers on pharmaceutical care, medication safety, supply chain, leadership development, return on investment and strategy development.
\nPatrick’s interest in personalized medicine with 3DP started in 2017. Since then, he has been involved in several 3DP initiatives, given presentations, and moderated podium discussions on how to elevate 3DP into clinical practice.<\/p>\n

 <\/p>\n

Niels Ouwerkerk (Doser)
\n<\/strong><\/em>Niels Ouwerkerk holds a PHD in Bio-Organic Synthesis from the Leiden University and has over 20 years of industrial experience in diverse industries, such as personal care, food specialties and pharmaceuticals. His expertise covers areas in analytical development and validation, formulation development, quality assurance, and regulatory compliance.<\/p>\n

 <\/p>\n

Mattias Paulsson (Hospital Pharmacy Uppsala University)
\n<\/strong><\/em>Mattias Paulsson, PhD, is deputy chief pharmacist at Uppsala University Hospital, Sweden, with extensive experience in hospital pharmacy, formulation science, and 3D printing of pharmaceuticals. He has led extemporaneous compounding units, including radiopharmaceuticals and clinical trial preparations, and served as a GMP-qualified person. His research focuses on patient safety, parenteral nutrition, IV compatibility, and innovative drug delivery. He supervises undergraduate and PhD students, lectures on formulation science, and has published 28 scientific articles. Paulsson is dedicated to advancing pharmacy practice through both clinical and academic initiatives.<\/p>\n

 <\/p>\n

Holger Reinhoff (DiHeSys)<\/strong><\/em><\/p>\n

 <\/p>\n

Niklas Sandler (CurifyLabs).
\n<\/strong><\/em>Niklas Sandler, PhD (Pharm,), Founder and Chief Technology Officer (CTO) at CurifyLabs. He has extensive experience in academia and industry, specializing in pharmaceutical product development and material science. His research in pharmaceutical technology has been published in over 100 papers in major international journals. Sandler’s academic work as professor at \u00c5bo Akademi University (2009-2019) focused on novel pharmaceutical manufacturing technologies, process analytics, formulations for additive manufacturing (3D printing) and material characterization.Between 2019-2022 he was Chief Technology Officer at Nanoform Finland Ltd. CurifyLabs was founded in 2021 and is CurifyLabs is offering a unique approach to compounding medicines in pharmacies and hospital pharmacies through high-quality 3D printing of personalized medicines on site in pharmacies.<\/p>\n

 <\/p>\n

Kirsten Schimmel (Leiden University Medical Center)
\n<\/strong><\/em>Kirsten Schimmel, PharmD, PhD is an associate professor in drug manufacturing. She is head of the GMP production facility of clinical pharmacy at the academic hospital of Leiden. The facility has GMP licenses for conventional medicines, ATMPs, small molecules and radiopharmaceuticals. She is also educational director of the Master of Pharmacy at the University of Leiden.
\nSince 2018 she is involved in research in 3D pharma printing, with the ultimate goal of bringing this innovative production technique to the point of care.<\/p>\n

 <\/p>\n

Laurens Schulpen (Service Pharmacy Woerden)
\n<\/strong><\/em>Laurens Schulpen has been a community pharmacist in Woerden since 2001. Together with four colleague pharmacists, they provide pharmaceutical care for a large part of Woerden. There are always one or two AIOS working in his pharmacy who are being trained to become community pharmacists. Besides education, Laurens has a broad interest in pharmaceutical care. Compounding and “baxtering” are important aspects of his pharmacy. Recently, the pharmacy acquired a 3D printer from Doser. Laurens is also active in administrative roles. He is the chairman of the Central College of Pharmacy Specialties, chairman of the Landelijke Eerstelijns Farmacie (LEF), a member of the Franchise Council of Service Apotheek, and a member of the NedAIS (representatives of all user associations of AIS in the Netherlands). Laurens is convinced that 3D printing of tablets will in the near future play an important role in personalized patient treatment.<\/p>\n

 <\/p>\n

Tilmann Spitz (GoatAM)
\n<\/strong><\/em>Tilmann Spitz is CEO and co-founder of goatAM. Before joining goatAM as CEO, Mr. Spitz worked in research at the Technical University of Cologne, where he also completed his master’s degree in mechanical engineering with a focus on automation technology. As part of his research activities, Mr. Spitz dealt with smart sensor technology, highly dynamic measuring systems and the implementation of AI algorithms in machine systems for quality control, among other things. The main focus of his work was additive manufacturing, where he created highly specialized machine systems for special applications and materials. For example, he developed 3D printing systems for construction foams, multi-material applications and pharmaceutical applications. In 2023, he founded goatAM with a 3D printing system for the decentralized production of individual pharmaceutical dosage forms.<\/p>\n

 <\/p>\n

Karel Stolper ( CbusineZ)
\n<\/strong>Karel Stolper is an expert in healthcare innovation and financing, with a background in health economics, management, and policy. He is the CEO of CbusineZ, the innovation and investment arm of CZ, where he oversees a diverse portfolio of healthcare ventures. His work focuses on fostering and scaling innovations that improve accessibility, efficiency, and quality in healthcare.<\/p>\n

With a PhD in Health Economics from Erasmus University and previous leadership roles in health insurance and healthcare strategy, Karel has gained understanding of regulated market dynamics and healthcare transformation. He is also a guest researcher at the Erasmus School of Health Policy and Management and serves on various boards, including those advancing self-care solutions and homecare innovation.<\/p>\n

 <\/p>\n

Jesse Swen (Leiden University Medical Center)
\n<\/strong><\/em>Jesse Swen PharmD, PhD is a full professor of clinical pharmacy, in particular translational pharmacogenetics. He works as a clinical pharmacist-clinical pharmacologist at the Department of Clinical Pharmacy & Toxicology, Leiden University Medical Center where he is the chair of the laboratory of the hospital pharmacy.
\nThe long-term central goal of his career is to improve the outcomes of drug treatment by gaining a better understanding of the genetic mechanisms that result in inter-individual variability in drug response.<\/p>\n

<\/div>\n

Ren\u00e9 Th\u00fcrmer (Federal Institute for Drugs and Medical Devices, Bonn)
\n<\/strong>Dr. Ren\u00e9 Th\u00fcrmer received his degree in chemistry and his Ph.D. in biochemistry from the University of T\u00fcbingen. He joined the BfArM (Federal Institute for Drugs and Medical Devices, Bonn, Germany) in 2000. He currently serves as a CMC reviewer and is Deputy Head of the Unit Pharmaceutical Biotechnology, Genetic and Reproductive Toxicology.
\nHis experience is in the field of formulation, manufacture and control of medicinal products, in particular in the field of oligonucleotides, peptides, proteins, liposomes, sustained release polymer drug products, depot formulations, polymer-conjugated drug products, natural and synthetic surfactants, nanomedicine and others.
\nHe is a member of the EMA Quality Innovation Group (QIG) established in 2022.<\/p>\n","protected":false},"excerpt":{"rendered":"

The 1st edition of the 3D PharmaPrint Healthcare Symposium will take place on Tuesday March 18th in Rotterdam, The Netherlands. The PharmaPrint Healthcare Symposium, a collaborative initiative by TNO and…<\/p>\n","protected":false},"author":3,"featured_media":4295,"template":"","meta":{"_acf_changed":false,"inline_featured_image":false,"_tribe_events_status":"","_tribe_events_status_reason":"","footnotes":""},"tags":[],"tribe_events_cat":[39],"class_list":["post-4968","tribe_events","type-tribe_events","status-publish","has-post-thumbnail","hentry","tribe_events_cat-conferences","cat_conferences"],"acf":[],"yoast_head":"\n3D PharmaPrint Healthcare Symposium | Het Congresbureau<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/hetcongresbureau.nl\/en\/evenement\/3d-pharmaprint-healthcare-symposium\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"3D PharmaPrint Healthcare Symposium | Het Congresbureau\" \/>\n<meta property=\"og:description\" content=\"The 1st edition of the 3D PharmaPrint Healthcare Symposium will take place on Tuesday March 18th in Rotterdam, The Netherlands. The PharmaPrint Healthcare Symposium, a collaborative initiative by TNO and…\" \/>\n<meta property=\"og:url\" content=\"https:\/\/hetcongresbureau.nl\/en\/evenement\/3d-pharmaprint-healthcare-symposium\/\" \/>\n<meta property=\"og:site_name\" content=\"Het Congresbureau\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-14T09:31:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/hetcongresbureau.nl\/wp-content\/uploads\/2025\/01\/logo-vierkant-scaled-e1737457120403.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2364\" \/>\n\t<meta property=\"og:image:height\" content=\"1701\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@HCB_nl\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"17 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/hetcongresbureau.nl\\\/en\\\/evenement\\\/3d-pharmaprint-healthcare-symposium\\\/\",\"url\":\"https:\\\/\\\/hetcongresbureau.nl\\\/en\\\/evenement\\\/3d-pharmaprint-healthcare-symposium\\\/\",\"name\":\"3D PharmaPrint Healthcare Symposium | Het Congresbureau\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/hetcongresbureau.nl\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/hetcongresbureau.nl\\\/en\\\/evenement\\\/3d-pharmaprint-healthcare-symposium\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/hetcongresbureau.nl\\\/en\\\/evenement\\\/3d-pharmaprint-healthcare-symposium\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/hetcongresbureau.nl\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/logo-vierkant-scaled-e1737457120403.jpg\",\"datePublished\":\"2025-01-20T11:23:05+00:00\",\"dateModified\":\"2026-04-14T09:31:36+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/hetcongresbureau.nl\\\/en\\\/evenement\\\/3d-pharmaprint-healthcare-symposium\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/hetcongresbureau.nl\\\/en\\\/evenement\\\/3d-pharmaprint-healthcare-symposium\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/hetcongresbureau.nl\\\/en\\\/evenement\\\/3d-pharmaprint-healthcare-symposium\\\/#primaryimage\",\"url\":\"https:\\\/\\\/hetcongresbureau.nl\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/logo-vierkant-scaled-e1737457120403.jpg\",\"contentUrl\":\"https:\\\/\\\/hetcongresbureau.nl\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/logo-vierkant-scaled-e1737457120403.jpg\",\"width\":2364,\"height\":1701},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/hetcongresbureau.nl\\\/en\\\/evenement\\\/3d-pharmaprint-healthcare-symposium\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/hetcongresbureau.nl\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Events\",\"item\":\"https:\\\/\\\/hetcongresbureau.nl\\\/en\\\/evenementen\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"3D PharmaPrint Healthcare Symposium\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/hetcongresbureau.nl\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/hetcongresbureau.nl\\\/en\\\/\",\"name\":\"Het Congresbureau\",\"description\":\"Het Congresbureau van het Erasmus MC\",\"publisher\":{\"@id\":\"https:\\\/\\\/hetcongresbureau.nl\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/hetcongresbureau.nl\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/hetcongresbureau.nl\\\/en\\\/#organization\",\"name\":\"Het Congresbureau\",\"url\":\"https:\\\/\\\/hetcongresbureau.nl\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/hetcongresbureau.nl\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/hetcongresbureau.nl\\\/wp-content\\\/uploads\\\/2021\\\/02\\\/het-congresbureau.svg\",\"contentUrl\":\"https:\\\/\\\/hetcongresbureau.nl\\\/wp-content\\\/uploads\\\/2021\\\/02\\\/het-congresbureau.svg\",\"width\":\"1024\",\"height\":\"1024\",\"caption\":\"Het Congresbureau\"},\"image\":{\"@id\":\"https:\\\/\\\/hetcongresbureau.nl\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/HCB_nl\",\"https:\\\/\\\/nl.linkedin.com\\\/showcase\\\/het-congresbureau-\u2013-erasmus-mc\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"3D PharmaPrint Healthcare Symposium | Het Congresbureau","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/hetcongresbureau.nl\/en\/evenement\/3d-pharmaprint-healthcare-symposium\/","og_locale":"en_US","og_type":"article","og_title":"3D PharmaPrint Healthcare Symposium | Het Congresbureau","og_description":"The 1st edition of the 3D PharmaPrint Healthcare Symposium will take place on Tuesday March 18th in Rotterdam, The Netherlands. The PharmaPrint Healthcare Symposium, a collaborative initiative by TNO and…","og_url":"https:\/\/hetcongresbureau.nl\/en\/evenement\/3d-pharmaprint-healthcare-symposium\/","og_site_name":"Het Congresbureau","article_modified_time":"2026-04-14T09:31:36+00:00","og_image":[{"width":2364,"height":1701,"url":"https:\/\/hetcongresbureau.nl\/wp-content\/uploads\/2025\/01\/logo-vierkant-scaled-e1737457120403.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@HCB_nl","twitter_misc":{"Est. reading time":"17 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/hetcongresbureau.nl\/en\/evenement\/3d-pharmaprint-healthcare-symposium\/","url":"https:\/\/hetcongresbureau.nl\/en\/evenement\/3d-pharmaprint-healthcare-symposium\/","name":"3D PharmaPrint Healthcare Symposium | Het Congresbureau","isPartOf":{"@id":"https:\/\/hetcongresbureau.nl\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/hetcongresbureau.nl\/en\/evenement\/3d-pharmaprint-healthcare-symposium\/#primaryimage"},"image":{"@id":"https:\/\/hetcongresbureau.nl\/en\/evenement\/3d-pharmaprint-healthcare-symposium\/#primaryimage"},"thumbnailUrl":"https:\/\/hetcongresbureau.nl\/wp-content\/uploads\/2025\/01\/logo-vierkant-scaled-e1737457120403.jpg","datePublished":"2025-01-20T11:23:05+00:00","dateModified":"2026-04-14T09:31:36+00:00","breadcrumb":{"@id":"https:\/\/hetcongresbureau.nl\/en\/evenement\/3d-pharmaprint-healthcare-symposium\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/hetcongresbureau.nl\/en\/evenement\/3d-pharmaprint-healthcare-symposium\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/hetcongresbureau.nl\/en\/evenement\/3d-pharmaprint-healthcare-symposium\/#primaryimage","url":"https:\/\/hetcongresbureau.nl\/wp-content\/uploads\/2025\/01\/logo-vierkant-scaled-e1737457120403.jpg","contentUrl":"https:\/\/hetcongresbureau.nl\/wp-content\/uploads\/2025\/01\/logo-vierkant-scaled-e1737457120403.jpg","width":2364,"height":1701},{"@type":"BreadcrumbList","@id":"https:\/\/hetcongresbureau.nl\/en\/evenement\/3d-pharmaprint-healthcare-symposium\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/hetcongresbureau.nl\/en\/"},{"@type":"ListItem","position":2,"name":"Events","item":"https:\/\/hetcongresbureau.nl\/en\/evenementen\/"},{"@type":"ListItem","position":3,"name":"3D PharmaPrint Healthcare Symposium"}]},{"@type":"WebSite","@id":"https:\/\/hetcongresbureau.nl\/en\/#website","url":"https:\/\/hetcongresbureau.nl\/en\/","name":"Het Congresbureau","description":"Het Congresbureau van het Erasmus MC","publisher":{"@id":"https:\/\/hetcongresbureau.nl\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/hetcongresbureau.nl\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/hetcongresbureau.nl\/en\/#organization","name":"Het Congresbureau","url":"https:\/\/hetcongresbureau.nl\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/hetcongresbureau.nl\/en\/#\/schema\/logo\/image\/","url":"https:\/\/hetcongresbureau.nl\/wp-content\/uploads\/2021\/02\/het-congresbureau.svg","contentUrl":"https:\/\/hetcongresbureau.nl\/wp-content\/uploads\/2021\/02\/het-congresbureau.svg","width":"1024","height":"1024","caption":"Het Congresbureau"},"image":{"@id":"https:\/\/hetcongresbureau.nl\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/HCB_nl","https:\/\/nl.linkedin.com\/showcase\/het-congresbureau-\u2013-erasmus-mc"]}]}},"_links":{"self":[{"href":"https:\/\/hetcongresbureau.nl\/en\/wp-json\/wp\/v2\/tribe_events\/4968","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/hetcongresbureau.nl\/en\/wp-json\/wp\/v2\/tribe_events"}],"about":[{"href":"https:\/\/hetcongresbureau.nl\/en\/wp-json\/wp\/v2\/types\/tribe_events"}],"author":[{"embeddable":true,"href":"https:\/\/hetcongresbureau.nl\/en\/wp-json\/wp\/v2\/users\/3"}],"version-history":[{"count":2,"href":"https:\/\/hetcongresbureau.nl\/en\/wp-json\/wp\/v2\/tribe_events\/4968\/revisions"}],"predecessor-version":[{"id":6224,"href":"https:\/\/hetcongresbureau.nl\/en\/wp-json\/wp\/v2\/tribe_events\/4968\/revisions\/6224"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/hetcongresbureau.nl\/en\/wp-json\/wp\/v2\/media\/4295"}],"wp:attachment":[{"href":"https:\/\/hetcongresbureau.nl\/en\/wp-json\/wp\/v2\/media?parent=4968"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/hetcongresbureau.nl\/en\/wp-json\/wp\/v2\/tags?post=4968"},{"taxonomy":"tribe_events_cat","embeddable":true,"href":"https:\/\/hetcongresbureau.nl\/en\/wp-json\/wp\/v2\/tribe_events_cat?post=4968"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}